Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB is a generic product labeled by Solco Healthcare US LLC, priced at $0.9753 per EA under NDC 43547045909. Its NADAC has been published 139 times since Oct 4, 2023.
FDA first approved this application on Apr 11, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB
candesartan cilexetil and hydrochlorothiazideStrength
16; 12.5 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547045909
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207455FDA Approved
4/11/2018
TE Code
AB
On Market Since
11/20/2017
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has been published 139 times since Oct 4, 2023, and over the history we have for it it has risen 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9753 per EA |
|---|---|
| All-time high | $1.4794 (Jan 10, 2024) |
| All-time low | $0.6502 (Nov 20, 2024) |
| 52-week high | $1.0596 |
| 52-week low | $0.7758 |
| Median price | $0.9712 |
| Average price | $0.9822 |
| Largest weekly change | +54.4% (Sep 18, 2024) |
| Weeks tracked | 139 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB, manufactured by Solco Healthcare US LLC, is $0.9753 per EA (NDC 43547045909), effective Aug 19, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has risen 6.5%. It has been tracked across 139 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
Since Oct 4, 2023, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has ranged from a low of $0.6502 (Nov 20, 2024) to a high of $1.4794 (Jan 10, 2024), with a median of $0.9712 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB (NDC 43547045909) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.